Ymera Pignochino

Assistant Professor

University of Turin

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ymera Pignochino is an Assistant Professor at the University of Turin, Italy. Her research focuses on innovative approaches in cancer treatment, including nanoparticle-delivered therapies, molecular profiling of leukemia, and exosome-based liquid biopsy methods for sarcomas. She has published extensively on topics such as the proteomic landscape of Ewing sarcoma, the effects of PARP1 inhibitors, and the interaction between immune cells and myxoid liposarcoma.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (20)

daniela cilloni

PROFESSOR

University of Turin

ITALY

Ymera Pignochino

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles

Nanoparticles-Delivered Circular RNA Strategy as a Novel Antitumor Approach

Comprehensive Molecular Profiling of NPM1-Mutated Acute Myeloid Leukemia Using RNAseq Approach

Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application

Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity in vivo

EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing’s Sarcoma and Chondrosarcoma

Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor Cells

PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas—A Preclinical and Translational Study

Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights.

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes.

Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group.

Phage display-based nanotechnology applications in cancer immunotherapy

High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series

Collaborators (20)

daniela cilloni

Valeria Leuci

Rossella Loria

Serena MARCHIO'

Veronica De Giorgis

Enrico Berrino

Caterina Mancarella

Massimo Donadelli

Sonia Capellero

Enzo Medico

Francesca D'Este

Umberto Miglio

Emiliano Dalla

Bernd Kasper

CANNELLA LUCIA

Falcioni Rita

Dario Sangiolo

Giorgia Giordano

Elisa Vigna

GIULIA MESIANO

Make your next move.